- **CD146**: CD146 is a cell surface marker that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is associated with increased stemness and aggressiveness in glioblastoma and activates YAP signaling.
- **CD14**: CD14 is an immunoreceptor that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is involved in antigen presentation and is regulated by NF-κB signaling.
- **CD33**: CD33 is an immunoreceptor that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is involved in antigen presentation and is regulated by NF-κB signaling.
- **CD44**: CD44 is a cell adhesion molecule that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is regulated by NF-κB signaling and is involved in cell proliferation and migration.
- **CD59**: CD59 is a cell adhesion molecule that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is regulated by NF-κB signaling and is involved in cell proliferation and migration.
- **CD209**: CD209 is a cell surface receptor that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is regulated by NF-κB signaling and is involved in cell proliferation and migration.
- **TNC**: TNC is a cell surface receptor that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is regulated by NF-κB signaling and is involved in cell proliferation and migration.
- **EGFR**: EGFR is a growth factor receptor that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. EGFR signaling promotes GBM cell invasion and maintains the clonogenic and tumorigenic potential of GSCs.
- **LDL Receptor**: The LDL receptor is a cell surface receptor that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is regulated by NF-κB signaling and is involved in cell proliferation and migration.
- **P65**: P65 is a subunit of the NF-κB transcription factor that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. P65 is a key regulator of NF-κB signaling and is often targeted for therapeutic interventions.
- **P50**: P50 is a subunit of the NF-κB transcription factor that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. P50 forms a heterodimer with p65, which is the main physiological function within the cell.
- **P52**: P52 is a subunit of the NF-κB transcription factor that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. P52 is formed through the maturation and division of p100.
- **P100**: P100 is a precursor form of the NF-κB transcription factor that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. P100 is ultimately hydrolyzed to produce the functional protein p52.
- **P105**: P105 is a precursor form of the NF-κB transcription factor that is highly expressed in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. P105 is ultimately hydrolyzed to produce the functional protein p50.
- **IκBα**: IκBα is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBα is phosphorylated and degraded upon activation of the NF-κB signaling pathway.
- **IκBβ**: IκBβ is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBβ is phosphorylated and degraded upon activation of the NF-κB signaling pathway.
- **IκBɛ**: IκBɛ is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBɛ is characterized by ankyrin repeats, which bind to the DNA-binding domains of transcription factors, thereby rendering them transcriptionally inactive.
- **Bcl-3**: Bcl-3 is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. Bcl-3 is characterized by ankyrin repeats, which bind to the DNA-binding domains of transcription factors, thereby rendering them transcriptionally inactive.
- **IκB Kinase (IKK)**: IKK is a protein complex that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IKK contains two catalytic subunits, IKKα and IKKβ, and a stent subunit, IKKγ.
- **IKKα**: IKKα is a catalytic subunit of the IKK complex that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IKKα is activated by NIK in the non-canonical NF-κB signaling pathway.
- **IKKβ**: IKKβ is a catalytic subunit of the IKK complex that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IKKβ is involved in the canonical NF-κB signaling pathway.
- **IKKγ**: IKKγ is a stent subunit of the IKK complex that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IKKγ is involved in the canonical NF-κB signaling pathway.
- **NIK**: NIK is a protein that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. NIK is activated by receptor activators for nuclear factor kappa B (RANK), B-cell activation factor (BAFFR), lymphtoxin β-receptor (LTβR), or CD40 in the non-canonical NF-κB signaling pathway.
- **RIP2**: RIP2 is a protein that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. RIP2 promotes SOX2 expression by upregulating the phosphorylation of p65, enhancing GBM cell stemness and resistance to TMZ.
- **PLEKHG5**: PLEKHG5 is a protein that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. PLEKHG5 induces the expression of O6-methylguanine-DNA methyltransferase (MGMT) by enhancing the phosphorylation of p65, promoting GBM cell resistance to TMZ.
- **AKIP1**: AKIP1 is a protein that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. AKIP1 promotes radiotherapy tolerance of GBM by regulating C-X-C Motif Chemokine Ligand 1/8 (CXCL1 and CXCL8)-mediated p65 phosphorylation.
- **LITAF**: LITAF is a protein that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. LITAF promotes target genes, including TNF-α, IL-6, CCL-2, etc., thereby further activating the NF-κB signal to promote a mesenchymal transition and increase the radiosensitivity of GBM.
- **ARPC1B**: ARPC1B is a protein that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. ARPC1B activates the NF-κB and STAT3 signaling pathways by inhibiting the TRIM21-mediated degradation of IFI16 and HuR, which promotes MES phenotype maintenance and radiotherapy resistance of GBM.
- **UBXN1**: UBXN1 is a protein that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. UBXN1 is regulated by LncRNA PRADX, which increases the trimethylation of H3K27 in the UBXN1 gene promoter through polycomb repressive complex 2 (PRC2)/DEAD box protein 5 (DDX5) complex recruitment.
- **ACTN4**: ACTN4 is a protein that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with primary GBM samples and cell lines. ACTN4 enhances and stabilizes interaction with the protein actinin alpha 4 (ACTN4), which leads to increased nuclear localization of the p65 and activation of NF-κB signaling.
- **NUSAP1**: NUSAP1 is a protein that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. NUSAP1 is upregulated by LINC01393, which sponges miR-128-3p, resulting in the development and progression of GBM via activating the NF-κB pathway.
- **NEAT1**: NEAT1 is a long non-coding RNA that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. NEAT1 is stabilized by PTRF/Cavin-1, which promotes the activity of NF-κB by inhibiting the expression of UBX domain protein 1 (UBXN1) via NEAT1 and enhancing the transcription of PD-L1 through NF-κB activation.
- **PD-L1**: PD-L1 is a protein that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. PD-L1 is transcribed by NF-κB activation, which promotes the immune evasion of GBM cells by regulating PD-1 binding and PD-L1-mediated T-cell cytotoxicity.
- **FBP1**: FBP1 is a protein that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. FBP1 is downregulated by GBE1, which enhances the Warburg effect to drive GBM progression.
- **IκB Kinase (IKK)**: IKK is a protein complex that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IKK contains two catalytic subunits, IKKα and IKKβ, and a stent subunit, IKKγ.
- **IκBα**: IκBα is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBα is phosphorylated and degraded upon activation of the NF-κB signaling pathway.
- **IκBβ**: IκBβ is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBβ is phosphorylated and degraded upon activation of the NF-κB signaling pathway.
- **IκBɛ**: IκBɛ is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBɛ is characterized by ankyrin repeats, which bind to the DNA-binding domains of transcription factors, thereby rendering them transcriptionally inactive.
- **Bcl-3**: Bcl-3 is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. Bcl-3 is characterized by ankyrin repeats, which bind to the DNA-binding domains of transcription factors, thereby rendering them transcriptionally inactive.
- **IκB Kinase (IKK)**: IKK is a protein complex that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IKK contains two catalytic subunits, IKKα and IKKβ, and a stent subunit, IKKγ.
- **IκBα**: IκBα is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBα is phosphorylated and degraded upon activation of the NF-κB signaling pathway.
- **IκBβ**: IκBβ is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBβ is phosphorylated and degraded upon activation of the NF-κB signaling pathway.
- **IκBɛ**: IκBɛ is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBɛ is characterized by ankyrin repeats, which bind to the DNA-binding domains of transcription factors, thereby rendering them transcriptionally inactive.
- **Bcl-3**: Bcl-3 is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. Bcl-3 is characterized by ankyrin repeats, which bind to the DNA-binding domains of transcription factors, thereby rendering them transcriptionally inactive.
- **IκB Kinase (IKK)**: IKK is a protein complex that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IKK contains two catalytic subunits, IKKα and IKKβ, and a stent subunit, IKKγ.
- **IκBα**: IκBα is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBα is phosphorylated and degraded upon activation of the NF-κB signaling pathway.
- **IκBβ**: IκBβ is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBβ is phosphorylated and degraded upon activation of the NF-κB signaling pathway.
- **IκBɛ**: IκBɛ is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. IκBɛ is characterized by ankyrin repeats, which bind to the DNA-binding domains of transcription factors, thereby rendering them transcriptionally inactive.
- **Bcl-3**: Bcl-3 is a protein that inhibits the function of NF-κB transcription factors in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion, and its expression is associated with poor prognosis. Bcl-3 is characterized by ankyrin repeats, which bind to the DNA-binding domains of transcription factors, thereby rendering them transcriptionally inactive.
- **IκB Kinase (IKK)**: IKK is a protein complex that is involved in the activation of NF-κB signaling in IDH-wildtype glioblastoma cancer cells. It is involved in cell proliferation, migration, and invasion,
